Progression of chronic renal failure.
Chronic renal failure is characterized by a persistently abnormal glomerular filtration rate. The rate of progression varies substantially. Several morphologic features are prominent: fibrosis, loss of native renal cells, and infiltration by monocytes and/or macrophages. Mediators of the process include abnormal glomerular hemodynamics, hypoxia, proteinuria, hypertension, and several vasoactive substances (ie, cytokines and growth factors). Several predisposing host factors may also contribute to the process. Treatments to delay progression are aimed at treating the primary disease and at strictly controlling the systemic blood pressure and proteinuria. The role of antihypertensive agents, statins, and use of other maneuvers such as protein restriction and novel approaches are also discussed herein.
Yu
Henry T
HT
Department of Medicine, University of South Carolina School of Medicine, Columbia, SC 29209, USA. henry.yu@med.va.gov
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D016923:Cell Death; D003167:Complement Activation; D018450:Disease Progression; D006439:Hemodynamics; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000628:therapy; D000860:Hypoxia; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D011507:Proteinuria / Q000188:drug therapy; D012907:Smoking / Q000009:adverse effects
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors